Some mutations can result in gain-of-function with subsequent increase in pyrin expression in FMF patients [26,27], while other mutations can result in pyrin knockdown resulting in increased IL-1β release and caspase-1 activation [28]. The gene discussed is MEFV; the disease is familial Mediterranean fever.